Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Bite and Sting Medicated Relief Pads

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
February 23, 2018
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
February 23, 2018
Manufacturer
CVS
Registration number
part348
NDC root
69842-856
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to provide temporary relief from pain and itching caused by minor cuts, scrapes, and minor burns. It works by soothing the affected area, helping you feel more comfortable as you heal. If you experience any of these minor skin irritations, this drug may be a helpful option for you.

Uses

If you’re dealing with minor cuts, scrapes, or burns, this medication can help provide temporary relief from pain and itching. It’s designed to soothe your skin and make you feel more comfortable while your injuries heal. Just remember, it’s meant for minor issues, so if you have more serious injuries, you should consult a healthcare professional.

Dosage and Administration

If you or your child is 2 years old or older, you can apply the medication directly to the affected area. Make sure to do this no more than 3 to 4 times a day for the best results.

If your child is under 2 years of age, it’s important to consult with a doctor before using this medication. They can provide guidance on the appropriate treatment for younger children. Always follow these instructions carefully to ensure safe and effective use.

What to Avoid

It's important to use this medication safely and effectively. To ensure your well-being, keep it out of reach of children. If your condition worsens, or if symptoms persist for more than 7 days or return shortly after improvement, stop using the medication and consult your doctor. Additionally, avoid contact with your eyes and make sure to use the product only as directed. Following these guidelines will help you use the medication safely.

Side Effects

It's important to be aware that this product is flammable, so you should avoid using it while smoking or near any heat or flame. If your condition worsens, or if your symptoms last more than seven days or improve only to return within a few days, you should stop using the product and consult a doctor.

Warnings and Precautions

You should be aware that this product is flammable, so it's important not to use it while smoking or near any heat or flames. Always keep it out of reach of children. If a child accidentally ingests it, seek professional help or contact a Poison Control Center immediately.

If your condition worsens, or if your symptoms last more than 7 days or improve only to return within a few days, stop using the product and call your doctor for further advice.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of this product during pregnancy has not been established. You should consult your doctor before using it, as there may be potential risks to your fetus that are not well-documented.

While there are no specific dosage modifications recommended for pregnant individuals, it's always best to seek guidance from a healthcare professional to ensure your safety and that of your baby. Caution is advised, so please prioritize open communication with your doctor regarding any medications you may consider.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or considerations mentioned regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

When considering this medication for your child, it's important to note that if your child is under 2 years old, you should consult a doctor before use. For children aged 2 years and older, you can apply the medication to the affected area, but be sure not to exceed 3 to 4 applications in a day.

Always keep the medication out of reach of children to prevent accidental ingestion. If your child accidentally swallows any of the medication, seek professional help or contact a Poison Control Center right away.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not include special monitoring or safety considerations tailored for patients with renal impairment (kidney issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your kidney health. They can provide guidance based on your individual situation.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help determine the best approach based on your liver function and overall health.

Drug Interactions

It's great to know that there are no reported interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature and keep it away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If the patient is under 2 years old, it's important to consult a doctor before use.

FAQ

What is the drug indicated for?

The drug is indicated for the temporary relief of pain and itching associated with minor cuts, scrapes, and minor burns.

How should I use this drug?

For adults and children 2 years of age and older, apply to the affected area not more than 3 to 4 times daily. For children under 2 years of age, ask a doctor.

What should I do if my condition worsens?

Stop use and ask a doctor if your condition worsens or if symptoms last more than 7 days or clear up and occur again within a few days.

Are there any warnings I should be aware of?

Yes, the drug is flammable; do not use while smoking or near heat or flame.

What precautions should I take when using this drug?

Keep out of reach of children, and in case of accidental ingestion, seek professional help or contact a Poison Control Center immediately.

Is this drug safe to use during pregnancy?

The safety of this product during pregnancy has not been established, so consult a doctor if pregnant or planning to become pregnant.

How should I store this drug?

Store at room temperature, protect from light, and keep the container tightly closed. Discard after opening.

Packaging Info

Below are the non-prescription pack sizes of Bite and Sting Medicated Relief Pads (benzocaine - 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Medicated Relief Pads.
Details

Drug Information (PDF)

This file contains official product information for Bite and Sting Medicated Relief Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor cuts, scrapes, and minor burns. It is intended for use in patients experiencing discomfort from these specific skin injuries.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area, not exceeding 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to keep the product out of reach of children. If the condition worsens, or if symptoms persist for more than 7 days or recur after clearing up, discontinue use and consult a healthcare professional. Additionally, avoid contact with eyes and use the product only as directed.

Warnings and Precautions

Flammability is a significant concern associated with this product. It is imperative that it not be used while smoking or in proximity to heat or open flames to prevent fire hazards.

To ensure safety, this product must be kept out of the reach of children. In the event of accidental ingestion, it is crucial to seek professional medical assistance or contact a Poison Control Center immediately.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days. These guidelines are essential for monitoring the patient's response to treatment and ensuring appropriate medical intervention when necessary.

Side Effects

Patients should be aware that the product is flammable and should not be used while smoking or near heat or flame.

In clinical practice, it is advised that patients discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. These precautions are essential to ensure patient safety and effective management of their condition.

Drug Interactions

There are no documented drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Bite and Sting Medicated Relief Pads (benzocaine - 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Medicated Relief Pads.
Details

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application is to the affected area, not exceeding 3 to 4 times daily.

It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate professional assistance should be sought, or contact a Poison Control Center.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. Potential risks to the fetus are not well-documented; therefore, caution is advised when considering the use of this product in pregnant individuals. There are no specific dosage modifications for pregnant patients; healthcare professionals should be consulted for guidance regarding use in this population.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, as with any medication, it is advisable to monitor breastfed infants for any potential adverse effects.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient effectively.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek professional medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, patients should also stop use and seek medical advice.

It is important to remind patients to avoid contact with their eyes while using this product. Furthermore, patients should be counseled to use the product only as directed to ensure safety and efficacy.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a doctor prior to use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Bite and Sting Medicated Relief Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Bite and Sting Medicated Relief Pads, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.